Login / Signup

A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment.

Muhammad Wasif SaifCarlos R BecerraMarwan G FakihWeijing SunLazar PopovicSmitha KrishnamurthiThomas J GeorgeMichelle A RudekDale R ShepardJiri SkopekVladimir SramekBojan ZaricIkuo YamamiyaKarim A BenhadjiKensuke HamadaYaohua HeLee Rosen
Published in: Cancer chemotherapy and pharmacology (2021)
NCT02301117, registration date: November 21, 2014.
Keyphrases
  • open label
  • metastatic colorectal cancer
  • clinical trial
  • randomized controlled trial
  • phase ii
  • radiation therapy
  • phase iii
  • phase ii study